📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Calretinin is a novel candidate marker for adverse ovarian effects of early life exposure to mixtures of endocrine disruptors in the rat (2020)

First Author: Johansson H

Attributed to: The human fetal liver: development and response to maternal drug use. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00204-020-02697-3

PubMed Identifier: 32221642

Publication URI: http://europepmc.org/abstract/MED/32221642

Type: Journal Article/Review

Parent Publication: Archives of Toxicology

Issue: 4

ISSN: 0340-5761